• Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) soared 25.9% following news that the company has received permission from the U.S. Food and Drug Administration to submit an experimental drug for approval
• Simulations Plus, Inc.’s (NASDAQ:SLP) shares gained 6.2% after posting fiscal third-quarter revenues of $6.75 million, outpacing the Zacks Consensus Estimate of $6 million
• Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) surged 41.4% following positive mid-stage trial results for its drug ralinepag
• Evogene Ltd’s (NASDAQ:EVGN) shares surged 10.8% after the company declared that it has reached an important stage in crop disease collaboration with Monsanto Company (NYSE:MON)
Simulations Plus, Inc. (SLP): Free Stock Analysis Report
Arena Pharmaceuticals, Inc. (ARNA): Free Stock Analysis Report
Amicus Therapeutics, Inc. (FOLD): Free Stock Analysis Report
Monsanto Company (MON): Free Stock Analysis Report
Original post
Zacks Investment Research